Skip to main content

GAIL to invest in Start-Ups operating in Focus Areas

New Delhi: In a bid to support the Start-Ups operating in identified Focus Areas, GAIL (India) Limited announced its plans to invest in such companies through its Start-Up initiative ‘Pankh’.   

GAIL has now opened a fresh Round for Solicitation of Investment Proposals from the Start-Ups operating in the Focus Areas, which mainly includes natural gas, petrochemicals, energy, project management, bio-manure marketing, nano materials, IoT, data mining, environment, health and social. The further details of Focus Areas are available on GAIL website under GAIL PANKH Section.

The Start-Ups that are interested in equity investment from GAIL can apply through link ‘GAIL PANKH’ on GAIL’s website link https://bit.ly/3w9clX1

The Solicitation Round is open from March 30, 2021 to May 30, 2021.

Comments

Popular posts from this blog

Mint Life Sciences launch BV-Clean (Bacteria and Virus Clean) which last for 7 days

Mint Life Sciences (P) Ltd, a research oriented pharma company, which is into manufacturing, marketing and export of pharmaceutical products, launched BV-Clean (Bacteria and Virus Clean)  brand of 7 Days Anti-Viral Coat and Surface Cleaner, approved by IIT Ropar (A Govt. of India Enterprise). The products are being available at highly competitive prices as compared to daily cleaners. BV Clean-Shield is another unique product which is long lasting, self disinfecting, anti-viral and anti-microbial surface coating for 100 Days. Sidharth Goel, Managing Director, Mint Life Sciences Pvt Ltd, said, “We have over 300 products under our own brand name, which include tablets, capsules, liquid syrups, ointments, dry powder and lotion etc. We also have a highly specialized range of disinfectants and surface coatings for safe and hygienic living in workplaces, public places and homes. We have an R&D tie up with IIT Ropar (A Govt of India Enterprise) for development of various innovative p...

Shuddhi Herbal Immunity Package turns patients Covid Negative in 3 days

Chandigarh , 22 July 2020 :  Award winning Ayurveda expert and motivational speaker - Acharya Manish, has initiated a social campaign to counter the spread of COVID 19. Acharya Manish uses age-old therapies of Ayurveda to promote the 5000 - years - old vedic science. It is noteworthy that Acharya Manish has founded ‘Shuddhi Ayurveda’ an Ayurvedic Clinic and Research Centre at Zirakpur, which already has presence across India through 105 clinics which are helping patients adopt Ayurveda to counter all types of diseases. To fight against COVID 19 an intense research conducted by Ayurvedic doctors under the guidance of Acharya Manish was done and an immunity boosting pack – ‘Shuddhi Herbal Immunity Package’ was made. Using this pack and specialised anti COVID medications Acharya Manish started an initiative to help needy people, who were not able to afford expensive medicines, against the Coronavirus. A helpline number   8273183731  was established, where cal...

A first for India, Punjab ophthalmic surgeon introduces path-breaking surgery to cure Glaucoma

Chandigarh :  A major stride has been made in the field of ophthalmology - the medical specialty dealing with diseases of the eyes. Dr Varun Baweja, an ophthalmic surgeon from Punjab has introduced a revolutionary iStent technique to cure Glaucoma in the eyes, similar to cardiovascular stents. Dr Varun Baweja, a pioneer in the eye stent technique, is the first eye surgeon of India to get a certification from England for carrying out the iStent inject surgery. This eye surgery is used to treat Glaucoma disease, commonly known as ‘Kala Motia’. "The best thing about this path breaking surgery is that the patients get the same medical intervention sitting in India which normally is available abroad at a heavy  cost," said Dr Baweja, a Consultant Ophthalmologist at the Baweja Multispeciality Hospital in Punjab's Roopnagar, near Chandigarh. It is pertinent to state that Dr Varun got his poster published in the American Academy of Ophthalmology Journal in 2009 and has perfo...